Rhythm Biosciences Limited (ASX:RHY)

Rhythm Biosciences Statistics

Total Valuation

ASX:RHY has a market cap or net worth of AUD 29.05 million. The enterprise value is 28.67 million.

Market Cap	29.05M
Enterprise Value	28.67M

Important Dates

The last earnings date was Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

ASX:RHY has 322.74 million shares outstanding. The number of shares has increased by 17.94% in one year.

Current Share Class	322.74M
Shares Outstanding	322.74M
Shares Change (YoY)	+17.94%
Shares Change (QoQ)	+10.21%
Owned by Insiders (%)	13.88%
Owned by Institutions (%)	7.69%
Float	232.24M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	9.10
PB Ratio	44.02
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-7.49
EV / Sales	8.98
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.74

Financial Position

The company has a current ratio of 0.84, with a Debt / Equity ratio of 1.68.

Current Ratio	0.84
Quick Ratio	0.72
Debt / Equity	1.68
Debt / EBITDA	n/a
Debt / FCF	-0.38
Interest Coverage	-55.90

Financial Efficiency

Return on equity (ROE) is -501.54% and return on invested capital (ROIC) is -166.61%.

Return on Equity (ROE)	-501.54%
Return on Assets (ROA)	-107.16%
Return on Invested Capital (ROIC)	-166.61%
Return on Capital Employed (ROCE)	-554.37%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	1.47
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +23.29% in the last 52 weeks. The beta is 2.10, so ASX:RHY's price volatility has been higher than the market average.

Beta (5Y)	2.10
52-Week Price Change	+23.29%
50-Day Moving Average	0.09
200-Day Moving Average	0.08
Relative Strength Index (RSI)	51.04
Average Volume (20 Days)	501,727

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:RHY had revenue of AUD 3.19 million and -3.83 million in losses. Loss per share was -0.01.

Revenue	3.19M
Gross Profit	2.97M
Operating Income	-3.73M
Pretax Income	-3.83M
Net Income	-3.83M
EBITDA	-3.53M
EBIT	-3.73M
Loss Per Share	-0.01

Balance Sheet

The company has 1.48 million in cash and 1.11 million in debt, giving a net cash position of 374,937 or 0.00 per share.

Cash & Cash Equivalents	1.48M
Total Debt	1.11M
Net Cash	374,937
Net Cash Per Share	0.00
Equity (Book Value)	659,892
Book Value Per Share	0.00
Working Capital	-347,407

Cash Flow

In the last 12 months, operating cash flow was -2.92 million and capital expenditures -23,210, giving a free cash flow of -2.94 million.

Operating Cash Flow	-2.92M
Capital Expenditures	-23,210
Free Cash Flow	-2.94M
FCF Per Share	-0.01

Margins

Gross margin is 92.95%, with operating and profit margins of -116.85% and -119.97%.

Gross Margin	92.95%
Operating Margin	-116.85%
Pretax Margin	-119.97%
Profit Margin	-119.97%
EBITDA Margin	-110.68%
EBIT Margin	-116.85%
FCF Margin	n/a

Dividends & Yields

ASX:RHY does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-17.94%
Shareholder Yield	n/a
Earnings Yield	-13.18%
FCF Yield	-10.14%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:RHY has an Altman Z-Score of -18.53 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-18.53
Piotroski F-Score	3